D tion therapy, complete resection of a tumor offers
|
|
- Zoe Woods
- 5 years ago
- Views:
Transcription
1 Determinants of Perioperative Morbidity and Mortality After Pneumonectomy Rakesh Wahi, MBBS, Marion J. McMurtrey, MD, Louis F. DeCaro, MD, Clifton F. Mountain, MD, Mohamed K. Ali, MD, Terry L. Smith, MS, and Jack A. Roth, MD Departments of Thoracic Surgery, Medical Specialties (Cardiopulmonary Section), and Biomathematics, The University of Texas, M.D. Anderson Cancer Center, Houston, Texas A total of 197 consecutive patients undergoing pneumonectomy at the M.D. Anderson Cancer Center from 1982 to 1987 were reviewed. Sixty-five variables were analyzed for the predictive value for perioperative risk. The operative mortality rate was 7% (14/197). Patients having a right pneumonectomy (n = 95) had a higher operative mortality rate (12%) than patients having a left pneumonectomy (l%, p < 0.05). The extent of resection correlated with the operative mortality rate (chest wall resection or extrapleural pneumonectomy, n = 39, 15%; versus simple or intrapericardial pneumonectomy, n = 158, 5%; p < 0.05). Patients whose predicted postopera- tive pulmonary function, by spirometry and xenon 133 regional pulmonary function studies, was a forced expiratory volume in 1 second > 1.5 L, forced expiratory volume in 1 second > 58% of the preoperative value, forced vital capacity > 2.5 L, or forced vital capacity > 0% of the preoperative value had a lower operative mortality rate (p < 0.05). Atrial arrhythmia was the most common postoperative complication (23%). Xenon 133 regional pulmonary function studies are useful in predicting the risks of pneumonectomy. ( ) espite recent progress in chemotherapy and radia- D tion therapy, complete resection of a tumor offers the best possibility for long-term survival in patients with lung cancer [l]. In some patients, a pneumonectomy with or without chest wall or pleural resection may be required to remove the entire tumor. Long-term survival after resection of pulmonary metastases has been well documented, and surgical resection may be a useful adjunct in the multimodality treatment of metastatic cancer [2]. In select cases, a pneumonectomy may be required for resection of the metastases. Extrapleural pneumonectomy may offer palliation and local control in some patients with pleural mesotheliomas [3]. It is well recognized that recent advances in anesthesia, intensive care, and invasive and noninvasive perioperative evaluation and monitoring have reduced the mortality rates for major pulmonary resections. However, pneumonectomy continues to be associated with the highest mortality rate for all types of pulmonary resection. In 1987, Krowka and associates [4] reported an 11% 30-day mortality rate for pneumonectomy. Weiss [l] reported a series of patients undergoing pulmonary resection for lung carcinoma with a mortality rate of 17% for pneumonectomy. An accurate current estimation of surgical risk is useful in weighing various therapeutic options. We, therefore, undertook a review of all patients undergoing pneu- Presented at the Thirty-fifth Annual Meeting of the Southern Thoracic Surgical Association, Marco Island, FL, Nov 10-12, Address reprint requests to Dr Roth, The University of Texas, M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 109, Houston, TX monectomy at M.D. Anderson Cancer Center from July 1982 to July The purpose of the study was to define the risk factors for patients undergoing pneumonectomy and to identify subgroups of patients at higher risk with preoperative criteria. Material and Methods Records of 197 patients undergoing pneumonectomy at M.D. Anderson Cancer Center were available for review. One hundred sixty-one patients underwent operation for primary carcinoma of the lung, 15 for mesothelioma, 15 for metastatic disease, 3 for carcinoid, 2 for lung sarcomas, and 1 for plasma cell granuloma. The operations were performed under the direct supervision of a faculty thoracic surgeon. Patients had a thorough preoperative evaluation to determine the tumor stage, as well as to estimate the risk of operation. All patients were evaluated by a senior staff surgeon for resectability. The patients were evaluated by the Section of Cardiopulmonary Medicine, where they underwent pulmonary function tests including regional pulmonary ventilation and perfusion using xenon 133 gas. Patients were not systematically excluded from operation based on the test results. For the xenon 133 test, the patients were studied in an upright position at rest during normal breathing. Eight scintillation detectors were positioned against the patient s back, with four over each lung. Regional pulmonary blood flow was determined by injection of 1 to 2 mci of xenon 133 dissolved in saline solution. Regional ventilation was determined from the distribution of a single tidal breath of xenon 133-air mixture and from the wash by The Society of Thoracic Surgeons /89/$3.50
2 34 WAHI ET AL in and wash out of the equilibration volume curve using the half time in seconds [5]. Using previously described formulas [, 71, we were able to predict lung functions after resection for these patients. Data regarding the patients cardiac status were retrieved, with special attention to any history of arrhythmias, coronary artery disease, hypertension, or cardiac failure. Using the criteria described by Goldman [8], a numerical value was assigned to each patient. Other preoperative variables analyzed in this study are as follows: General medical condition Diabetes Creatinine level Hemoglobin level Serum albumin level Tumor characteristics Type Preoperative stage Final stage Surgical factors Extent of resection Additional procedures Completion pneumonectomy Side of resection Time taken Stapler use Staff surgeon Transfusion requirements Postoperative variables Length of mechanical ventilation Length of intensive care unit stay Length of hospitalization Pulmonary edema Bronchopleural fistula Atelectasis Wound infection Other complications Patients dying within 30 days of operation or during the same hospitalization were considered operative deaths. Based on the clinical course of the patients, we were able to classify five deaths as resulting from cardiac causes, two deaths from pulmonary causes, six deaths from cardiopulmonary causes, and one death from technical causes. All postoperative and intraoperative complications, regardless of their impact on the hospital stay, were noted. These included arrhythmias, premature ventricular contractions, pulmonary edema, pneumonia, bronchopleural fistula, wound infections, intubation longer than 48 hours, atelectasis, and secretions requiring therapeutic bronchoscopy. The necessity for pneumonectomy was determined by the staff surgeon at the time of operation. All patients with primary lung cancer underwent complete lymph node mapping. The extent of resection was primarily determined by the tumor size and local extension. In this series, 92 patients (4%) had a simple pneumonectomy with lymph node dissection, whereas patients (34%) had an intrapericardial pneumonectomy. The other 39 patients (20%) required resection of the chest wall, pleura, or diaphragm. Eighteen patients (10%) had prior pulmonary resection and had a completion pneumonectomy. In addition, 39 patients had mediastinoscopy, 5 had an anterior mediastinotomy, 2 had a concomitant tracheostomy, 1 had a staging adrenalectomy, 1 had a concomitant thymectomy, and 2 were operated on via a midline sternotomy incision. The incidence of surgical complications including deaths was compared for patients according to the demographic and disease characteristics, pulmonary functions, and surgical variables. Differences were compared by,$ tests. All p values are two-tailed. Results The mean (t standard error of the mean) age of patients in this series was 55 t 0.8 yr. There were 137 men and 0 women. The mean postoperative hospital stay was days; the mean intensive care unit stay was days. Patients required a mean of hours of mechanical ventilation. The mortality rate was 7%, and this was not significantly influenced by age, sex, or Goldman criteria (Table 1). Patients who had a right pneumonectomy had a higher operative mortality rate (12%) compared with patients who had a left pneumonectomy (1%)( p < 0.05). This difference was independent of other factors. Patients who had chest wall resection, extrapleural pneumonectomy, or resection of the diaphragm had a mortality rate of 15%, compared with 5% for patients who had a simple or intrapericardial pneumonectomy (p < 0.05). Transfusion requirements greater than 3 units increased the operative mortality rate from 4% to 17% ( p < 0.05). However, there was a statistically significant correlation between the extent of resection and transfusion requirements, indicating that transfusion was not an independent determinant of operative mortality. The mean total volume of fluids given during the perioperative period (24-hour period after induction of anesthesia) was 5.4 k 0.8 L. The total volume of fluid was not significantly increased in those patients who died after operation. The volume of fluids given perioperatively did not differ significantly for patients receiving a right compared with left pneumonectomy. Patients undergoing a completion pneumonectomy had a mortality rate of 11% compared with.7% for other patients. This difference was not statistically significant. Patients with a preoperative forced vital capacity (FVC) less than 85% of the preoperative predicted normal value had a mortality rate of ll%, which was significantly ( p < 0.05) higher than that of patients with an FVC greater than or equal to 85% of predicted (3%). We were unable to show any statistically significant differences in mortality based on preoperative forced expiratory volume in 1 second (FEV,), ratio of FEV,/FVC, absolute FVC, or forced expiratory flow (FEF). Using the regional ventilation perfusion studies and standard pulmonary function tests, we calculated the
3 ~~ WAHIETAL 35 MORTALITY AFTER FNEUMONECTOMY Table 1. Differences in Operative Mortality for Various Criteria Criterion Age <70 years 270 years Sex Male Female Goldman s criteria 59 >9 Side Right Left Extent of resection Simple In trapericardial Extended Transfusions None 1-3 >3 Completion pneumonectomy a Determined by 2 analysis = not significant. No. of Deaths/ No. of Mortality P Patients (%) Value / / /21 13/95 Ill02 4/92 4/ /39 3/93 4/4 7/ C C predicted postresection FEV, and FVC (Table 2). Patients with a predicted postoperative FEV, of 1.5 L or more had no perioperative deaths, compared with a perioperative mortality rate of 9% in patients with a lower predicted FEV, (p < 0.05). Patients with a predicted FEV, less than 41% of normal had a mortality rate of 1% compared with a mortality rate of 3% for patients with a predicted FEV, greater than or equal to 41% of normal. Patients with a predicted postoperative FVC greater than or equal to 2.13 L had a mortality rate of approximately 2.5% compared with 11% in patients with a lower predicted FVC (p < 0.05). Patients with a predicted postoperative FVC greater than or equal to 51% of normal had a mortality rate of approximately 1% compared with 12% in patients with a lower predicted FVC (p < 0.05). Additional procedures such as mediastinoscopy and mediastinotomy did not adversely affect mortality rate. Atrial arrhythmias were the most common complication, occurring in 4 patients (23%). Atrial arrhythmias were seen in 23% of patients undergoing simple pneumonectomy compared with 20% of patients requiring intrapericardial dissection (not significant). Patients who developed atrial arrhythmias had a longer stay in the intensive care unit (4.8 versus 2.5 days) and a longer postoperative hospital stay (13.7 versus 9.3 days) compared with patients who did not develop atrial arrhythmias (p < 0.05). Patients undergoing simple pneumonectomy had a 3% incidence of complications compared with 53% for intrapericardial resection. Other procedures such as chest wall resection, extrapleural pneumonectomy, and diaphragm resection increased the complication rate to 7%. The incidence of all nonfatal complications increased with the number of transfusions required. Patients who required no transfusion had a 39% incidence of complications, whereas patients requiring three or more transfusions had a 1% incidence of complications. Because of the correlation between extent of resection and transfusion, the transfusion requirement was not an independent predictor of operative complications. We were unable to show any significant effect of age, sex, preoperative lung function tests, or predicted lung function on the incidence of all postoperative complications. Cardiac failure developed in 18 patients (9%), showing no correlation with age or Goldman s criteria. Eighteen patients required ventilation longer than 48 hours. These patients had a mean preoperative FEV, of 9% of predicted normal compared with a mean preoperative FEV, of 79% of predicted normal for patients requiring ventilation for 48 hours or less (p < 0.05). No significant differences in other measures of preoperative spirometry could be demonstrated. However, when analyzing predicted postoperative lung function, significant differences were noted (Table 3). Patients requiring prolonged ventilation had a mean predicted FEV, of 43% of normal compared with 48% ( p < 0.05) and mean predicted FVC of 45% compared with 52% ( p < 0.05) for patients requiring mechanical ventilation for 48 hours or less. Other pulmonary complications, such as major atelectasis, pneumonia, and retained secretions, occurred in 13 patients (.%). Technical complications such as excessive blood loss (> units), loss of arterial or venous control, failure of the stapler to fire correctly, and inadvertent injury to unrelated structures occurred in 13 patients (.%). Eight patients (4%) developed a bronchopleural fistula. All bronchopleural fistulas developed on the right side (p < 0.05). Table 2. Predicted Postoperative Lung Function Variable No. of P Patients Deathsa Valueb FEV, (L) (0) < (9) FVC (L) (2.5) < (11) Percent FEV, Percent FVC 241% 251% (3) 1 (1) <41% (51% (1) 11 (12) c0.05 (0.05 a Numbers in parentheses are percentages. ysis. FEV, = forced expiratory volume in 1 second. capacity. Determined by,$ anal- FVC = forced vital
4 3 WAHIETAL 1989;48:3%7 Table 3. Lung Function in Patients Requiring Prolonged Ventilation Ventilation" >48Hours 548Hours p Variable (n = 18) (n = 179) Valueb Percent predicted 9% f 0.04% 79% % normal FEV, (preoperative) Predicted 1.2? f 0.07 FEVI (L) Percent predicted 43% f 0.02% 48%? 0.01% FEV, Predicted 1.93 f FVC (L) Percent predicted 45% * 0.02% 52% % FVC a Data are reported as mean 2 standard deviation. Student's t test. FEV, = forced expiratory volume in 1 second; capacity; = not significant. Comment Determined by FVC = forced vital Two large series [4, 91 describing the risks of pneumonectomy have recently been published. One multicenter study [9] reported a mortality rate of approximately 7% for patients undergoing simple pneumonectomy for carcinoma of the lung. The other series [4] described patients with a variety of diseases that required a pneumonectomy. The mortality rate in that series was 13%. Our mortality rate of 7% is consistent with these and earlier reports [lo]. In a separate study, Reichel [lo] showed no significant increase in mortality related to age. Kohman and associates [ll] reported an increase in the operative mortality rate from 2.4% for patients younger than 0 years of age to 7.4% in patients older than 0 years. This study considered all types of lung resections. Ginsberg and co-workers [9] reported an increased mortality rate in patients older than 70 years. However, further analysis of their data for pneumonectomies alone shows a mortality rate of 5.9% for patients older than 70 years compared with 8% in patients younger than 70 years. Our results show no significant increase in mortality related to age. Reviewing patients older than 70 years of age, Breyer and co-workers [12] reported a mortality rate of 5% in patients with either lobectomy or pneumonectomy. The increased risk associated with right pneumonectomy is documented in various publications [lo, 13, 141. Gerson [15] reported a higher mortality rate in patients with a preoperative FEV, of less than 70% of the predicted normal value. Similar results were reported independently by Boushy and co-workers [1]. However, Keagy and associates [17] reported no significant effects of preoperative FEV, and FVC on mortality. In this study, ventilation perfusion scans were not performed and no attempt was made to estimate postresection lung function. In an experimental clinical study, Adams and colleagues [18] showed the importance of cardiopulmonary reserve as a determinant of risk. Since then, many investigators have reported the effects of tests of predicted postresection lung function on mortality. Earlier studies were done using a double-lumen Carlen tube placed under local anesthesia. Neuhaus and Cheriack [19], in such a study, showed good correlation between predicted lung function and complications. The introduction of ventilation perfusion studies using xenon 133 gas obviated the need for double-lumen tubes for such tests. Various investigators [, 71 have reported the technique and the reliability of these studies in calculating predicted lung function. These predictors are very useful clinically because regional and overall pulmonary functions remain stable after pneumonectomy [20]. In our series, we were able to show significant differences in mortality based on predicted lung function. The incidence of atrial arrhythmias after pneumonectomy varies from % to 29% in various series [21, 221. We report an incidence of 23%, but were unable to demonstrate any differences based on the extent of resection. This study shows that the operative mortality rate after pneumonectomy has not changed greatly over the last two decades. Most of the deaths in this series were from cardiac and cardiopulmonary causes. Using the preoperative xenon 133 regional ventilation and perfusion studies in conjunction with overall pulmonary function tests and demographic criteria, we are able to identify patients at higher risk. These patients should receive more intensive perioperative evaluation and hemodynamic monitoring to reduce their operative risk. Such efforts should primarily be directed at the cardiopulmonary system. Furthermore, the risk of operation must be carefully balanced with a better chance for survival in patients requiring extended resection. References 1. Weiss W. Operative mortality and five year survival rates in patients with bronchogenic carcinoma. Chest 1974;: Mubn JF, Holmes EC, Vernon SE, et al. Pulmonary resection for metastatic sarcoma. Am J Surg 1980;140: Davalle ML, Faber LP, Kittle CF, et al. Extrapleural pneumonectomy for diffuse malignant mesothelioma. Ann Thorac Surg 198;42: Krowka MJ, Pairolero PC, Trastek VF, et al. Cardiac dysrythmias following pneumonectomy. Chest 1987;91: Miller JM, Ali MK, Howe CD. Clinical determination of regional pulmonary function during normal breathing using xenon 133. Am Rev Respir Dis 1970;101:21%29.. Ali MK, Mountain CF, Ewer MS, et al. Predicting loss of pulmonary function after pulmonary resection for bronchogenic carcinoma. Chest 1980; Bria WF, Kanarek DJ, Kazemi M. Prediction of postoperative pulmonary function following thoracic operations. J Thorac Cardiovasc Surg 1983;8:18-92.
5 WAHIETAL Goldman L. Complications of noncardiac surgery. Ann Surg 1983;198:78& Ginsberg RJ, Hill LD, Eagan RT, et al. Modern thirty day mortality for surgical resection in lung cancer. J Thorac Cardiovasc Surg 1983;8: Reichel J. Assessment of operative risk of pneumonectomy. Chest 1972;2: Kohman LJ, Meyer JA, Ikino PM, et al. Random versus predictable risk of mortality after thoracotomy for lung cancer. J Thorac Cardiovasc Surg 198;91: Breyer RH, Zippe C, Pharr W, et al. Thoracotomy in patients over age seventy years. J Thorac Cardiovasc Surg 1981; 81: Evans EWT. Resection for bronchial carcinoma in the elderly. Thorax 1973;28: Higgins GA, Beebe GW. Bronchogenic carcinoma. Factors in survival. Arch Surg 197; Gerson G. Respiratory function tests and postoperative mortality. Br J Anaesth 199;41: Boushy SF, Billings DM, North LB, et al. Clinical course related to preoperative and postoperative lung functions in patients with bronchogenic carcinoma. Chest 1971;59: Keagy BA, Schorlemmer GR, Murray GF, et al. Correlation of preoperative pulmonary function testing with clinical course in patients after pneumonectomy. 1983; 3~ Adams WE, Perkins JF, Harrison RW, et al. The significance of cardiopulmonary reserve in the late results of pneumonectomy for carcinoma of the lung. Dis Chest 1957;32: Neuhaus H, Cheriack. A bronchospirometric method of estimating the effect of pneumonectomy on the maximal breathing capacity. J Thorac Cardiovasc Surg 198;55: Ali MK, Ewer MS, Atallah MR, et al. Regional and overall pulmonary function changes in lung cancer. J Thorac Cardiovasc Surg 1983;8: Cerny CI. The prophylaxis of cardiac arrhythmias complicating pulmonary surgery. J Thorac Surg 1957;34: Shields TW, Ujiki GT. Digitalization for prevention of arrhythmias following pulmonary surgery. Surg Gynecol Obstet 198;12:743-.
A carcinoma of the lung reported by Graham and. Predicted Pulmonary Function and Survival After Pneumonectomy for Primary Lung Carcinoma
Predicted Pulmonary Function and Survival After Pneumonectomy for Primary Lung Carcinoma Joe B. Putnam, Jr, MD, David E. Lammermeier, MD, Rolando Colon, MD, Marion J. McMurtrey, MD, Mohammed K. Ali, MD,
More informationPredicting Postoperative Pulmonary Function in Patients Undergoing Lung Resection*
Predicting Postoperative Pulmonary Function in Patients Undergoing Lung Resection* Bernhardt G. Zeiher, MD; Thomas ]. Gross, MD; Jeffery A. Kern, MD, FCCP; Louis A. Lanza, MD, FCCP; and Michael W. Peterson,
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is a publisher's version. For additional information about this publication click this link. http://hdl.handle.net/2066/23566
More informationPreoperative Workup for Pulmonary Resection. Kristen Bridges, M.D. Richmond University Medical Center January 21, 2016
Preoperative Workup for Pulmonary Resection Kristen Bridges, M.D. Richmond University Medical Center January 21, 2016 Patient Presentation 50 yo male with 70 pack year smoking history Large R hilar lung
More informationParenchymal air leak is a frequent complication after. Pleural Tent After Upper Lobectomy: A Randomized Study of Efficacy and Duration of Effect
Pleural After Upper Lobectomy: A Randomized Study of Efficacy and Duration of Effect Alessandro Brunelli, MD, Majed Al Refai, MD, Marco Monteverde, MD, Alessandro Borri, MD, Michele Salati, MD, Armando
More informationCarcinoma of the Lung
THE ANNALS OF THORACIC SURGERY Journal of The Society of Thoracic Surgeons and the Southern Thoracic Surgical Association VOLUME 1 I - NUMBER 3 0 MARCH 1971 Carcinoma of the Lung M. L. Dillon, M.D., and
More informationComplete surgical excision remains the greatest potential
ORIGINAL ARTICLE Wedge Resection for Non-small Cell Lung Cancer in Patients with Pulmonary Insufficiency: Prospective Ten-Year Survival John P. Griffin, MD,* Charles E. Eastridge, MD, Elizabeth A. Tolley,
More informationIndex. Note: Page numbers of article titles are in boldface type
Index Note: Page numbers of article titles are in boldface type A Acute coronary syndrome, perioperative oxygen in, 599 600 Acute lung injury (ALI). See Lung injury and Acute respiratory distress syndrome.
More informationComplex Thoracoscopic Resections for Locally Advanced Lung Cancer
Complex Thoracoscopic Resections for Locally Advanced Lung Cancer Duke Thoracoscopic Lobectomy Workshop March 21, 2018 Thomas A. D Amico MD Gary Hock Professor of Surgery Section Chief, Thoracic Surgery,
More informationAkihiro Hayashi, MD, Shinzo Takamori, MD, Masahiro Mitsuoka, MD, Keisuke Miwa, MD, Mari Fukunaga, MD, Keiko Matono, MD, and Kazuo Shirouzu, MD
Case Report The UPAO Test in Preoperative Evaluation for Major Pulmonary Resection: An Operative Case with Markedly Improved Ventilatory Function after Radical Pulmonary Resection for Lung Cancer Associated
More informationPostoperative Mortality in Lung Cancer Patients
Review Postoperative Mortality in Lung Cancer Patients Kanji Nagai, MD, Junji Yoshida, MD, and Mitsuyo Nishimura, MD Surgery for lung cancer frequently results in serious life-threatening complications,
More information141 Ann Thorac Surg , Aug Copyright by The Society of Thoracic Surgeons
Completion Pneumonectomy: Indications, Complications, and Results Eilis M. McGovern, M.B.B.Ch., Victor F. Trastek, M.D., Peter C. Pairolero, M.D., and W. Spencer Payne, M.D. ABSTRACT From 958 through 985,
More informationMEDIASTINAL LYMPH NODE METASTASIS IN PATIENTS WITH CLINICAL STAGE I PERIPHERAL NON-SMALL-CELL LUNG CANCER
MEDIASTINAL LYMPH NODE METASTASIS IN PATIENTS WITH CLINICAL STAGE I PERIPHERAL NON-SMALL-CELL LUNG CANCER Tsuneyo Takizawa, MD a Masanori Terashima, MD a Teruaki Koike, MD a Hideki Akamatsu, MD a Yuzo
More informationThoracoscopic Lobectomy for Locally Advanced Lung Cancer. Masters of Minimally Invasive Thoracic Surgery Orlando September 19, 2014
for Locally Advanced Lung Cancer Masters of Minimally Invasive Thoracic Surgery Orlando September 19, 2014 Thomas A. D Amico MD Gary Hock Endowed Professor and Vice Chair of Surgery Chief Thoracic Surgery
More informationShort- and Long-Term Outcomes after Pneumonectomy for Primary Lung Cancer
Original Article Short- and Long-Term Outcomes after Pneumonectomy for Primary Lung Cancer Takeshi Kawaguchi, MD, Takashi Tojo, MD, Keiji Kushibe, MD, Michitaka Kimura, MD, Yoko Nagata, MD, and Shigeki
More informationSurvival and Prognosis After Pneumonectomy for Lung Cancer in the Elderly
and Prognosis After Pneumonectomy for Lung Cancer in the Elderly Yutaka Mizushima, MD, Hirofumi Noto, MD, Shigeki Sugiyama, MD, Yoshinori Kusajima, MD, Ryouhei Yamashita, MD, Tatsuhiko Kashii, MD, and
More informationCarcinoma of the Lung in Women
Carcinoma of the Lung in Marvin M. Kirsh, M.D., Jeanne Tashian, M.A., and Herbert Sloan, M.D. ABSTRACT The 5-year survival of 293 men and of 78 women undergoing pulmonary resection and mediastinal lymph
More informationRoutine reinforcement of bronchial stump after lobectomy or pneumonectomy with pedicled pericardial flap (PPF)
Routine reinforcement of bronchial stump after lobectomy or pneumonectomy with pedicled pericardial flap (PPF) Abstract The results of 25 cases underwent a pedicled pericardial flap coverage for the bronchial
More informationPrapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital
Prapaporn Pornsuriyasak, M.D. Pulmonary and Critical Care Medicine Ramathibodi Hospital Only 20-30% of patients with lung cancer are potential candidates for lung resection Poor lung function alone ruled
More informationT3 NSCLC: Chest Wall, Diaphragm, Mediastinum
for T3 NSCLC: Chest Wall, Diaphragm, Mediastinum AATS Postgraduate Course April 29, 2012 Thomas A. D Amico MD Professor of Surgery, Chief of Thoracic Surgery Duke University Health System Disclosure No
More informationLYMPH NODE METASTASIS IN SMALL PERIPHERAL ADENOCARCINOMA OF THE LUNG
LYMPH NODE METASTASIS IN SMALL PERIPHERAL ADENOCARCINOMA OF THE LUNG Tsuneyo Takizawa, MD a Masanori Terashima, MD a Teruaki Koike, MD a Takehiro Watanabe, MD a Yuzo Kurita, MD b Akira Yokoyama, MD b Keiichi
More informationHISTORY SURGERY FOR TUMORS WITH INVASION OF THE APEX 15/11/2018
30 EACTS Annual Meeting Barcelona, Spain 1-5 October 2016 SURGERY FOR TUMORS WITH INVASION OF THE APEX lung cancer of the apex of the chest involving any structure of the apical chest wall irrespective
More informationThoracic Surgery; An Overview
Thoracic Surgery What we see Thoracic Surgery; An Overview James P. Locher, Jr, MD Methodist Cardiovascular and Thoracic Surgery Lung cancer Mets Fungus and TB Lung abcess and empyema Pleural based disease
More informationSubsequent Pulmonary Resection for Bronchogenic Carcinoma After Pneumonectomy
ORIGINAL ARTICLES: GENERAL THORACIC Subsequent Pulmonary Resection for Bronchogenic Carcinoma After Pneumonectomy Jessica S. Donington, MD, Daniel L. Miller, MD, Charles C. Rowland, BS, Claude Deschamps,
More informationTreatment of Clinical Stage I Lung Cancer: Thoracoscopic Lobectomy is the Standard
Treatment of Clinical Stage I Lung Cancer: Thoracoscopic Lobectomy is the Standard AATS General Thoracic Surgery Symposium May 5, 2010 Thomas A. D Amico MD Professor of Surgery, Duke University Medical
More informationPreoperative assessment for lung resection. RA Dyer
Preoperative assessment for lung resection RA Dyer 2016 The ideal assessment of operative risk would identify every patient who could safely tolerate surgery. This ideal is probably unattainable... Mittman,
More informationReasons for conversion during VATS lobectomy: what happens with increased experience
Review Article on Thoracic Surgery Page 1 of 5 Reasons for conversion during VATS lobectomy: what happens with increased experience Dario Amore, Davide Di Natale, Roberto Scaramuzzi, Carlo Curcio Division
More informationFariba Rezaeetalab Associate Professor,Pulmonologist
Fariba Rezaeetalab Associate Professor,Pulmonologist rezaitalabf@mums.ac.ir Patient related risk factors Procedure related risk factors Preoperative risk assessment Risk reduction strategies Age Obesity
More informationCompletion pneumonectomy for lung cancer
Journal of BUON 7: 235-240, 2002 2002 Zerbinis Medical Publications. Printed in Greece ORIGINAL ARTICLE Completion pneumonectomy for lung cancer N. Baltayiannis, D. Anagnostopoulos, N. Bolanos, L. Tsourelis
More informationClinical Commissioning Policy Proposition: Robotic assisted lung resection for primary lung cancer
Clinical Commissioning Policy Proposition: Robotic assisted lung resection for primary lung cancer Reference: NHS England B10X03/01 Information Reader Box (IRB) to be inserted on inside front cover for
More informationMedian Sternotomy for Pneumonectomy in Patients With Pulmonary Complications of Tuberculosis
Median Sternotomy for Pneumonectomy in Patients With Pulmonary Complications of Tuberculosis Cliff P. Connery, MD, James Knoetgen III, MD, Constantine E. Anagnostopoulos, MD, and Madeline V. Svitak, BS,
More informationAdam J. Hansen, MD UHC Thoracic Surgery
Adam J. Hansen, MD UHC Thoracic Surgery Sometimes seen on Chest X-ray (CXR) Common incidental findings on computed tomography (CT) chest and abdomen done for other reasons Most lung cancers discovered
More informationUniversity of Florida Department of Surgery. CardioThoracic Surgery VA Learning Objectives
University of Florida Department of Surgery CardioThoracic Surgery VA Learning Objectives This service performs coronary revascularization, valve replacement and lung cancer resections. There are 2 faculty
More informationSURGICAL TECHNIQUE. Radical treatment for left upper-lobe cancer via complete VATS. Jun Liu, Fei Cui, Shu-Ben Li. Introduction
SURGICAL TECHNIQUE Radical treatment for left upper-lobe cancer via complete VATS Jun Liu, Fei Cui, Shu-Ben Li The First Affiliated Hospital of Guangzhou Medical College, Guangzhou, China ABSTRACT KEYWORDS
More informationAlthough the international TNM classification system
Prognostic Significance of Perioperative Serum Carcinoembryonic Antigen in Non-Small Cell Lung Cancer: Analysis of 1,000 Consecutive Resections for Clinical Stage I Disease Morihito Okada, MD, PhD, Wataru
More informationLOBECTOMY COMBINED WITH VOLUME REDUCTION FOR PATIENTS WITH LUNG CANCER AND ADVANCED EMPHYSEMA
LOBECTOMY COMBINED WITH VOLUME REDUCTION FOR PATIENTS WITH LUNG CANCER AND ADVANCED EMPHYSEMA Steven R. DeMeester, MD* G. Alexander Patterson, MD R. Sudhir Sundaresan, MD Joel D. Cooper, MD Objective:
More informationNon-Small Cell Lung Cancer: Disease Spectrum and Management in a Tertiary Care Hospital
Non-Small Cell Lung Cancer: Disease Spectrum and Management in a Tertiary Care Hospital Muhammad Rizwan Khan,Sulaiman B. Hasan,Shahid A. Sami ( Department of Surgery, The Aga Khan University Hospital,
More informationBronchogenic Carcinoma
A 55-year-old construction worker has smoked 2 packs of ciggarettes daily for the past 25 years. He notes swelling in his upper extremity & face, along with dilated veins in this region. What is the most
More informationResults of surgical resection in patients over the age of 70 years with non small-cell lung cancer
European Journal of Cardio-thoracic Surgery 11 (1997) 432 439 Results of surgical resection in patients over the age of 70 years with non small-cell lung cancer U. Morandi, A. Stefani, M. Golinelli, C.
More informationProper Treatment Selection May Improve Survival in Patients With Clinical Early-Stage Nonsmall Cell Lung Cancer
Proper Treatment Selection May Improve Survival in Patients With Clinical Early-Stage Nonsmall Cell Lung Cancer Özcan Birim, MD, A. Pieter Kappetein, MD, PhD, Tom Goorden, MD, Rob J. van Klaveren, MD,
More informationTumour size as a prognostic factor after resection of lung carcinoma
Tumour size as a prognostic factor after resection of lung carcinoma A. S. SOORAE AND R. ABBEY SMITH Thorax, 1977, 32, 19-25 From the Cardio-Thoracic Unit, Walsgrave Hospital, Clifford Bridge Road, Coventry
More informationSurgery has been proven to be beneficial for selected patients
Thoracoscopic Lung Volume Reduction Surgery Robert J. McKenna, Jr, MD Surgery has been proven to be beneficial for selected patients with severe emphysema. Compared with medical management, lung volume
More informationPredicting pulmonary complications after pneumonectomy for lung cancer q
European Journal of Cardio-thoracic Surgery 23 (2003) 201 208 www.elsevier.com/locate/ejcts Predicting pulmonary complications after pneumonectomy for lung cancer q Abstract Francisco Javier Algar*, Antonio
More informationCarcinoma of the Lung: A Clinical Review
Carcinoma of the Lung: A Clinical Review R. Samuel Cromartie, 111, M.D., Edward F. Parker, M.D., James E. May, M.D., John S. Metcalf, M.D., and David M. Bartles, M.S. ABSTRACT Records of 702 patients with
More informationDoes preoperative predictive lung functions correlates with post surgical lung functions in lobectomy?
Preoperative and post surgical lung functions in lobectomy Original Research Article ISSN: 2394-0026 (P) Does preoperative predictive lung functions correlates with post surgical lung functions in lobectomy?
More informationORIGINAL ARTICLE. Incidence and risk factors for acute lung injury after open thoracotomy for thoracic diseases
ORIGINAL ARTICLE Incidence and risk factors for acute lung injury after open thoracotomy for thoracic diseases Shihua Yao 1*, Teng Mao 1*, Wentao Fang 1, Meiying Xu 2, Wenhu Chen 1 1 Department of Thoracic
More informationThoracoscopic Lobectomy: Technical Aspects in Years of Progress
Thoracoscopic Lobectomy: Technical Aspects in 2015 16 Years of Progress 8 th Masters of Minimally Invasive Thoracic Surgery Orlando September 25, 2015 Thomas A. D Amico MD Gary Hock Professor of Surgery
More informationThe Role of Radiation Therapy
The Role of Radiation Therapy and Surgery in the Treatment of Bronchogenic Carcinoma R Adams Cowley, M.D., Morris J. Wizenberg, M.D., and Eugene J. Linberg, M.D. A study of the combined use of preoperative
More informationThe surgeon: new surgical aproaches
The surgeon: new surgical aproaches Paul Van Schil, MD Department of Thoracic and Vascular Surgery Antwerp University, Belgium no disclosures, no conflict of interest Malignant pleural mesothelioma: clinical,
More informationPneumonectomy After Induction Rx: Is it Safe?
Pneumonectomy After Induction Rx: Is it Safe? David J. Sugarbaker, M.D. Director, Chief, Division of Thoracic Surgery The Olga Keith Weiss Chair of Surgery of Medicine at, Pneumonectomy after induction
More informationIn 1978, Cooper and associates first described resecting
Median Sternotomy Versus Thoracotomy to Resect Primary Lung Cancer: Analysis of 815 Cases James W. Asaph, MD, John R. Handy, Jr, MD, Gary L. Grunkemeier, PhD, E. Charles Douville, MD, Andrew C. Tsen, MD,
More informationAssessment of Operative Risk in Patients Undergoing Lung Resection* Importance of Predicted Pulmonary Function
Assessment of Operative Risk in Patients Undergoing Lung Resection* Importance of Predicted Pulmonary Function David]. Kearney, M.D.; Thomas H. Lee, M.D.; John]. Reilly, M.D., F.C.C.A. ; Malcolm M. DeCamp,
More informationORIGINAL ARTICLE. Thoracoscopic minimally invasive surgery for non-small cell lung cancer in patients with chronic obstructive pulmonary disease
ORIGINAL ARTICLE Thoracoscopic minimally invasive surgery for non-small cell lung cancer in patients with chronic obstructive pulmonary disease Fei Cui 1,2*, Jun Liu 1,2*, Wenlong Shao 1,2, Jianxing He
More informationThe Value of Adjuvant Radiotherapy in Pulmonary and Chest Wall Resection for Bronchogenic Carcinoma
The Value of Adjuvant Radiotherapy in Pulmonary and Chest Wall Resection for Bronchogenic Carcinoma G. A. Patterson, M.D., R. Ilves, M.D., R. J. Ginsberg, M.D., J. D. Cooper, M.D., T. R. J. Todd, M.D.,
More informationSURVIVAL AND FUNCTION AFTER SLEEVE LOBECTOMY FOR LUNG CANCER
SURVIVAL AND FUNCTION AFTER SLEEVE LOBECTOMY FOR LUNG CANCER Henning A. Gaissert, MD Douglas J. Mathisen, MD Ashby C. Moncure, MD Alan D. Hilgenberg, MD Hermes C. Grillo, MD John C. Wain, MD ~ Between
More informationIn the past, pulmonary metastases (PM) were considered
Original Article The Role of Extended Pulmonary Metastasectomy Monica Casiraghi, MD,* Patrick Maisonneuve, Eng, Daniela Brambilla, Msc,* Francesco Petrella, MD,* Piergiorgio Solli, MD,* Juliana Guarize,
More informationThirty years of surgery for carcinoma of the bronchus
Thorax 1983;38:428-432 Thirty years of surgery for carcinoma of the bronchus JR BELCHER From the London Chest and Middlesex Hospitals, London ABSTRACr A study has been made of 8781 patients with bronchial
More informationM expected to arise in 1.6% to 3.0% of all patients. Multiple Primary Lung Carcinomas: Prognosis and Treatment
Multiple Primary Lung Carcinomas: Prognosis and Treatment Todd K. Rosengart, MD, Nael Martini, MD, Pierre Ghosn, MD, and Michael Burt, MD, PhD Thoracic Service, Department of Surgery, Memorial-Sloan Kettering
More informationSite of Recurrence in Patients. of the Lung Resected for Cure. with Stages I and I1 Carcinoma
Site of Recurrence in Patients with Stages I and I1 Carcinoma of the Lung Resected for Cure Steven C. Immerman, M.D., Robert M. Vanecko, M.D., Willard A. Fry, M.D., Louis R. Head, M.D., and Thomas W. Shields,
More informationMethods ROLE OF OPEN LUNG BIOPSY IN PATIENTS WITH DIFFUSE LUNG INFILTRATES AND ACUTE RESPIRATORY FAILURE
ROLE OF OPEN LUNG BIOPSY IN PATIENTS WITH DIFFUSE LUNG INFILTRATES AND ACUTE RESPIRATORY FAILURE Li-Hui Soh, Chih-Feng Chian, Wen-Lin Su, Horng-Chin Yan, Wann-Cherng Perng, and Chin-Pyng Wu Background
More informationcame from a carcinoma and in 12 from a sarcoma. Ninety lesions were intrapulmonary and the as the chest wall and pleura. Details of the primary
Thorax 1982;37:366-370 Thoracic metastases MARY P SHEPHERD From the Thoracic Surgical Unit, Harefield Hospital, Harefield ABSTRACI One hundred and four patients are reviewed who were found to have thoracic
More informationLung cancer pleural invasion was recognized as a poor prognostic
Visceral pleural invasion classification in non small cell lung cancer: A proposal on the basis of outcome assessment Kimihiro Shimizu, MD a Junji Yoshida, MD a Kanji Nagai, MD a Mitsuyo Nishimura, MD
More informationLung Cancer Resection
Lung Cancer Resection Introduction The occurrence of lung cancer has increased dramatically over the last 50 years. Your health care provider may have recommended an operation to remove your lung cancer.
More informationSuperior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis
ORIGINAL ARTICLES: Superior and Basal Segment Lung Cancers in the Lower Lobe Have Different Lymph Node Metastatic Pathways and Prognosis Shun-ichi Watanabe, MD, Kenji Suzuki, MD, and Hisao Asamura, MD
More informationLung Cancer Clinical Guidelines: Surgery
Lung Cancer Clinical Guidelines: Surgery 1 Scope of guidelines All Trusts within Manchester Cancer are expected to follow this guideline. This guideline is relevant to: Adults (18 years and older) with
More informationSurgical treatment of bullous lung disease
Surgical treatment of bullous lung disease PD POTGIETER, SR BENATAR, RP HEWITSON, AD FERGUSON Thorax 1981 ;36:885-890 From the Respiratory Clinic, Groote Schuur Hospita', and Departments of Medicine, Anaesthetics,
More informationA Comparative Study of Video-Assisted Thoracic Surgery with Thoracotomy for Middle Lobe Syndrome
World J Surg (2017) 41:780 784 DOI 10.1007/s00268-016-3777-6 ORIGINAL SCIENTIFIC REPORT A Comparative Study of Video-Assisted Thoracic Surgery with Thoracotomy for Middle Lobe Syndrome Jian Li 1,2 Chengwu
More informationThe Journal of Thoracic and Cardiovascular Surgery
Accepted Manuscript Can We Make Pneumonectomy Great Again? Kenneth A. Kesler, MD PII: S0022-5223(18)31793-8 DOI: 10.1016/j.jtcvs.2018.06.048 Reference: YMTC 13173 To appear in: The Journal of Thoracic
More informationDLCO and postpneumonectomy complications RELATIONSHIP OF CARBON MONOXIDE PULMONARY DIFFUSING CAPACITY TO POSTOPERATIVE CARDIOPULMONARY COMPLICATIONS I
RELATIONSHIP OF CARBON MONOXIDE PULMONARY DIFFUSING CAPACITY TO POSTOPERATIVE CARDIOPULMONARY COMPLICATIONS IN PATIENTS UNDERGOING PNEUMONECTOMY Jeng-Shing Wang Respiratory Medicine Section, Vancouver
More informationLung Cancer in Octogenarians: Factors Affecting Morbidity and Mortality After Pulmonary Resection
ORIGINAL ARTICLES: SURGERY: The Annals of Thoracic Surgery CME Program is located online at http://cme.ctsnetjournals.org. To take the CME activity related to this article, you must have either an STS
More informationof Pulmonary Decortication
Physiological Evaluation of Results of Pulmonary Decortication Jeremy R. Morton, M.D., Samuel F. Boushy, M.D., and Gene A. Guinn, M.D. A reasona aggressive surgical approach to the treatment of trapped
More informationPreoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection
Preoperative Chemotherapy Does Not Increase Complications After Nonsmall Cell Lung Cancer Resection Emilie Perrot, MD, Benoit Guibert, MD, Pierre Mulsant, MD, Sonia Blandin, MD, Isabelle Arnaud, MD, Pascal
More informationLong-term respiratory function recovery in patients with stage I lung cancer receiving video-assisted thoracic surgery versus thoracotomy
Original Article Long-term respiratory function recovery in patients with stage I lung cancer receiving video-assisted thoracic surgery versus thoracotomy Tae Yun Park 1,2, Young Sik Park 2 1 Division
More informationLung Cancer Resection on Cardiopulmonary Bypass. Daniel J. Boffa, MD Yale University
Lung Cancer Resection on Cardiopulmonary Bypass Daniel J. Boffa, MD Yale University None related to talk Disclosures Disclaimers I love operating on CPB Disclaimers I love operating on CPB I avoid it for
More informationThe Itracacies of Staging Patients with Suspected Lung Cancer
The Itracacies of Staging Patients with Suspected Lung Cancer Gerard A. Silvestri, MD,MS, FCCP Professor of Medicine Medical University of South Carolina Charleston, SC silvestri@musc.edu Staging Lung
More informationImmediate pulmonary dysfunction in ischemic heart disease patients undergoing off-pump versus on-pump CABG
Available online at www.sciencedirect.com ScienceDirect Journal of the Egyptian Society of Cardio-Thoracic Surgery 24 (2016) 15e20 http://www.journals.elsevier.com/journal-of-the-egyptian-society-of-cardio-thoracic-surgery/
More informationMarcel Th. M. van Rens, MD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans R. J. Elbers, MD, PhD; and Jules M. M. van den Bosch, MD, PhD, FCCP
Prognostic Assessment of 2,361 Patients Who Underwent Pulmonary Resection for Non-small Cell Lung Cancer, Stage I, II, and IIIA* Marcel Th. M. van Rens, MD; Aart Brutel de la Rivière, MD, PhD, FCCP; Hans
More informationComparative efficacy of different modules on pulmonary functions after lung resection
International Surgery Journal Gandhi S et al. Int Surg J. 2017 Aug;4(8):2770-2776 http://www.ijsurgery.com pissn 2349-3305 eissn 2349-2902 Original Research Article DOI: http://dx.doi.org/10.18203/2349-2902.isj20173416
More informationSurgical management of lung cancer
Surgical management of lung cancer Nick Roubos FRACS Cardiothoracic Surgeon Box Hill Hospital, Epworth Eastern Thoracic Oncology Non Small Cell Lung Cancer (NSCLC) Small Cell Lung Cancer Mesothelioma Pulmonary
More informationImpact of Tidal Volume on Complications after Thoracic Surgery
Management of One-lung Ventilation Impact of Tidal Volume on Complications after Thoracic Surgery ABSTRACT Background: The use of lung-protective ventilation (LPV) strategies may minimize iatrogenic lung
More informationTHORACIK RICK. Lungs. Outline and objectives Richard A. Malthaner MD MSc FRCSC FACS
THORACIK RICK Outline and objectives Lungs Management of a solitary lung nodule Mediastinum Management of a mediastinal mass Pleura Management of a pleural fluid & pneumothorax Esophagus & Stomach Management
More informationPreoperative Evaluation of Patients Undergoing Lung Resection Surgery* Debapriya Datta, MD; and Bimalin Lahiri, MD, FCCP
reviews Preoperative Evaluation of Patients Undergoing Lung Resection Surgery* Debapriya Datta, MD; and Bimalin Lahiri, MD, FCCP Lung cancer continues to be the leading case of cancer deaths in the United
More informationLung Cancer-a primer. Sai Yendamuri, MD Professor and Chair, Dept of Thoracic Surgery,RPCI,Buffalo
Lung Cancer-a primer Sai Yendamuri, MD Professor and Chair, Dept of Thoracic Surgery,RPCI,Buffalo CLINICAL CATEGORIES THE SOLITARY PULMONARY NODULE MULTIPLE PULMONARY NODULES Differential Diagnosis Malignant
More informationVideo-Mediastinoscopy Thoracoscopy (VATS)
Surgical techniques Video-Mediastinoscopy Thoracoscopy (VATS) Gunda Leschber Department of Thoracic Surgery ELK Berlin Chest Hospital, Berlin, Germany Teaching Hospital of Charité Universitätsmedizin Berlin
More informationThe right middle lobe is the smallest lobe in the lung, and
ORIGINAL ARTICLE The Impact of Superior Mediastinal Lymph Node Metastases on Prognosis in Non-small Cell Lung Cancer Located in the Right Middle Lobe Yukinori Sakao, MD, PhD,* Sakae Okumura, MD,* Mun Mingyon,
More informationVATS after induction therapy: Effective and Beneficial Tips on Strategy
VATS after induction therapy: Effective and Beneficial Tips on Strategy AATS Focus on Thoracic Surgery Mastering Surgical Innovation Las Vegas Nevada Oct. 27-28 2017 Scott J. Swanson, M.D. Professor of
More informationLA TIMECTOMIA ROBOTICA
LA TIMECTOMIA ROBOTICA Prof. Giuseppe Marulli UOC Chirurgia Toracica Università di Padova . The thymus presents a challenge to the surgeon not only as a structure that may be origin of benign and malignant
More informationQuality of Life (QOL) versus Curability for Lung Cancer Surgery
Quality of Life (QOL) versus Curability for Lung Cancer Surgery Hirokuni Yoshimura, MD Standard operations for lung cancer patients are generally accepted as performing lobectomy or pneumonectomy on the
More informationPATIENT CHARACTERISTICS AND PREOPERATIVE DATA (ecrf 1).
PATIENT CHARACTERISTICS AND PREOPERATIVE DATA (ecrf 1). 1 Inform Consent Date: / / dd / Mmm / yyyy 2 Patient identifier: Please enter the 6 digit Patient identification number from your site patient log
More informationModeling major lung resection outcomes using classification trees and multiple imputation techniques
European Journal of Cardio-thoracic Surgery 34 (2008) 1085 1089 www.elsevier.com/locate/ejcts Modeling major lung resection outcomes using classification trees and multiple imputation techniques Mark K.
More informationCase presentation. Paul De Leyn, MD, PhD Thoracic Surgery University Hospitals Leuven Belgium
Case presentation Paul De Leyn, MD, PhD Thoracic Surgery University Hospitals Leuven Belgium Perspectives in Lung Cancer Brussels 6-7 march 2009 LEUVEN LUNG CANCER GROUP Department of Thoracic Surgery
More informationDoes chemotherapy increase the risk of respiratory complications after pneumonectomy?
Does chemotherapy increase the risk of respiratory complications after pneumonectomy? Francesco Leo, MD, a PierGiorgio Solli, MD, a Giulia Veronesi, MD, a Davide Radice, PhD, b Antonio Floridi, MD, a Roberto
More informationLung-Volume Reduction Surgery ARCHIVED
Lung-Volume Reduction Surgery ARCHIVED Policy Number: Original Effective Date: MM.06.008 04/15/2005 Line(s) of Business: Current Effective Date: PPO; HMO; QUEST 03/22/2013 Section: Surgery Place(s) of
More informationConflicts of Interest
Anesthesia for Major Abdominal Cancer Resection John E. Ellis MD Adjunct Professor University of Pennsylvania johnellis1700@gmail.com Conflicts of Interest 1 Upper Abdominal Surgery Focus on oncologic
More informationSTS General Thoracic Surgery Database (GTSD) Update
STS General Thoracic Surgery Database (GTSD) Update Benjamin D. Kozower, MD, MPH Professor of Surgery Chair, STS GTSD Co-Director, Surgical Outcomes Research Center Washington University St. Louis, MO
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: lung_volume_reduction_surgery 4/1996 3/2018 3/2019 3/2018 Description of Procedure or Service Emphysema is
More informationMinimally Invasive Esophagectomy- Valuable. Jayer Chung, MD University of Colorado Health Sciences Center December 11, 2006
Minimally Invasive Esophagectomy- Valuable Jayer Chung, MD University of Colorado Health Sciences Center December 11, 2006 Overview Esophageal carcinoma What is minimally invasive esophagectomy (MIE)?
More informationClinical results of sublobar resection versus lobectomy or more extensive resection for lung cancer patients with idiopathic pulmonary fibrosis
Original Article Clinical results of sublobar resection versus lobectomy or more extensive resection for lung cancer patients with idiopathic pulmonary fibrosis Seok Joo 1, Dong Kwan Kim 2, Hee Je Sim
More informationFacing Surgery for Lung Cancer? Learn about minimally invasive da Vinci Surgery
Facing Surgery for Lung Cancer? Learn about minimally invasive da Vinci Surgery Treatments & Surgery Options: The treatment and surgical options for the most common lung cancer, non-small cell lung cancer,
More informationLung cancer is a major cause of cancer deaths worldwide.
ORIGINAL ARTICLE Prognostic Factors in 3315 Completely Resected Cases of Clinical Stage I Non-small Cell Lung Cancer in Japan Teruaki Koike, MD,* Ryosuke Tsuchiya, MD, Tomoyuki Goya, MD, Yasunori Sohara,
More information